Clinical Trial Update: Irinotecan-Eluting Beads in Treating Patients With Refractory Metastatic Colon or Rectal Cancer That Has Spread to the Liver [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating irinotecan-eluting beads for treating colorectal cancer with liver metastases was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Liver Metastases
• Rectal Cancer

Drugs mentioned

• Irinotecan-eluting beads (irinotecan-eluting beads)

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Liver Metastases, Mucinous Adenocarcinoma of the Colon | Phase 1 | Status: TERMINATED